| Cas No.: | |
| Chemical Name: | BMS986202 |
| Synonyms: | BMS986202;BMS-986202,BMS 986202 |
| SMILES: | C1(C2N=CC(F)=CN=2)C=CC=C(NC2C=C(NC(=O)C3CC3)N=CC=2C(NC([2H])([2H])[2H])=O)C=1OC |
| Formula: | C22H21FN6O3 |
| M.Wt: | 439.456 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Publication: | J Med Chem . 2021 Jan 14;64(1):677-694. doi: 10.1021/acs.jmedchem.0c01698. Epub 2020 Dec 28. |
| Description: | BMS-986202 (BMS-986202, AM-152) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 18 and 9 nM in calcium mobilisation and β-arrestin assays; fully inhibits the response to LPA in calcium mobilisation, β-arrestin, cAMP, GTPγS and RhoA functional assays; BMS-986202 is currently in Phase II clinical trials for idiopathic pulmonary fibrosis. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
